Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Klus Pharma Inc.
Klus Pharma Inc.
Atos Medical AB
Ohio State University Comprehensive Cancer Center
Stanford University
Fuda Cancer Hospital, Guangzhou
Icahn School of Medicine at Mount Sinai
National Cancer Institute (NCI)
University of Plymouth